We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITOT icon
326
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$47.9M 0.05%
602,623
+11,220
+2% +$992K
ISRG icon
327
Intuitive Surgical
ISRG
$139B
$47.9M 0.05%
255,490
-27,671
-10% -$5.94M
BSX icon
328
Boston Scientific
BSX
$73.1B
$47.9M 0.05%
1,235,731
-575,643
-32% -$23.1M
FDS icon
329
Factset
FDS
$10.1B
$47.6M 0.05%
118,990
+27,486
+30% +$11.6M
WRB icon
330
W.R. Berkley
WRB
$26.3B
$47.4M 0.05%
1,100,624
+730,929
+198% +$31.7M
CMG icon
331
Chipotle Mexican Grill
CMG
$40.7B
$47.4M 0.05%
1,576,350
+94,850
+6% +$2.94M
MCHP icon
332
Microchip Technology
MCHP
$44.2B
$47.2M 0.05%
773,007
+89,628
+13% +$5.89M
TLH icon
333
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
$47.1M 0.05%
432,609
+301,634
+230% +$35.7M
ABNB icon
334
Airbnb
ABNB
$111B
$47.1M 0.05%
448,528
-679
-0.2% -$75.3K
KKR icon
335
KKR & Co
KKR
$93.2B
$47.1M 0.05%
1,094,329
-179,569
-14% -$9.07M
EMR icon
336
Emerson Electric
EMR
$88.5B
$46.2M 0.05%
631,574
+10,243
+2% +$851K
HEI.A icon
337
HEICO Corp Class A
HEI.A
$37B
$46.1M 0.05%
402,118
-25,006
-6% -$3.01M
REGN icon
338
Regeneron Pharmaceuticals
REGN
$83.2B
$45.9M 0.05%
66,585
-1,120
-2% -$705K
MKC icon
339
McCormick & Company Non-Voting
MKC
$14.3B
$45.8M 0.05%
643,161
+2,790
+0.4% +$234K
TDG icon
340
TransDigm Group
TDG
$67.6B
$45.8M 0.05%
87,262
-1,766
-2% -$1.05M
CRL icon
341
Charles River Laboratories
CRL
$13.2B
$45.6M 0.05%
231,503
+107,047
+86% +$23.1M
ICLR icon
342
Icon
ICLR
$12.8B
$44.9M 0.05%
244,578
-16,155
-6% -$3.52M
OXY icon
343
Occidental Petroleum
OXY
$58.6B
$44.9M 0.05%
730,873
+207,708
+40% +$13.3M
NOBL icon
344
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$44.8M 0.05%
1,121,366
-37,018
-3% -$1.64M
DGRW icon
345
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$44.5M 0.05%
826,294
+70,794
+9% +$4.19M
LNG icon
346
Cheniere Energy
LNG
$54.9B
$44.3M 0.04%
267,158
+30,929
+13% +$4.69M
KLAC icon
347
KLA
KLAC
$252B
$44.3M 0.04%
1,464,490
+43,360
+3% +$1.5M
EFV icon
348
iShares MSCI EAFE Value ETF
EFV
$30B
$44.2M 0.04%
1,147,736
-84,143
-7% -$3.59M
ATO icon
349
Atmos Energy
ATO
$28.4B
$43.9M 0.04%
430,938
+8,408
+2% +$963K
VT icon
350
Vanguard Total World Stock ETF
VT
$81.2B
$43.9M 0.04%
556,232
-22,535
-4% -$1.98M

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.